$heff's $tation of $tocks & $olid DD

[barefootrunner]

PCYC - Pharmacyclics strength an opporunity to take some profits, says RBC Capital

RBC Capital continues to view Pharmacyclics as one its favorite longs but sees some risk of a post-ASH sell-off. The firm continues to rate shares an Outperform given its proven robust efficacy of PCI-32765. :theflyonthewall

Agree 100%. Eyeing Jan 2012 puts. I think this bloated stock will experience post-ASH sell the news. Plus Rodman & Renshaw gave them a buy with PT = $20. R&R are kings of the PIPE and I wouldn't be surprised to see PCYC lay the PIPE after ASH.